Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Antioxidants (Basel, Switzerland)
|
April 30, 2021
Genetic Inactivation of Peroxiredoxin-I Impairs the Growth of Human Pancreatic Cancer Cells
Hajar Dahou, Marie-Albane Minati, Patrick Jacquemin, et al.
Antioxidants (Basel, Switzerland)
|
August 6, 2021
N-Acetylcysteine Reduces the Pro-Oxidant and Inflammatory Responses during Pancreatitis and Pancreas Tumorigenesis
Marie-Albane Minati, Maxime Libert, Hajar Dahou, et al.
Oral Oncology
|
May 31, 2024
Study of the PD-L1 expression, T-cells density and immunoscore in paired baseline tumor biopsies and surgical specimens in squamous cell carcinoma of the oral cavity
Simon Beyaert, Aléna Borys, Pamela Baldin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2025
Tumor-informed ctDNA assay to predict outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with PD-1 inhibitor
Natasha Honoré, George Laliotis, Vasily N Aushev, et al.
Cancer Research
|
February 19, 2021
Dynamic Regulation of Expression of KRAS and Its Effectors Determines the Ability to Initiate Tumorigenesis in Pancreatic Acinar Cells
Mohamad Assi, Younes Achouri, Axelle Loriot, et al.
Access Microbiology
|
July 23, 2025
Primary iliac bone tuberculosis: a case report
Hajar Dahou, Fataou Saley Younoussa, Imane Aragon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2023
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor
Natasha Honoré, Athenaïs van der Elst, Anna Dietz, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 25, 2026
Reciprocal signaling-metabolic crosstalk between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers
Engy Vigneron, Julie Vignau, Olivier Lowyck, et al.
Nature Communications
|
January 31, 2025
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma
Valentin Van den Bossche, Julie Vignau, Engy Vigneron, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Antioxidants (Basel, Switzerland)
|
April 30, 2021
Genetic Inactivation of Peroxiredoxin-I Impairs the Growth of Human Pancreatic Cancer Cells
Hajar Dahou, Marie-Albane Minati, Patrick Jacquemin, et al.
Antioxidants (Basel, Switzerland)
|
August 6, 2021
N-Acetylcysteine Reduces the Pro-Oxidant and Inflammatory Responses during Pancreatitis and Pancreas Tumorigenesis
Marie-Albane Minati, Maxime Libert, Hajar Dahou, et al.
Oral Oncology
|
May 31, 2024
Study of the PD-L1 expression, T-cells density and immunoscore in paired baseline tumor biopsies and surgical specimens in squamous cell carcinoma of the oral cavity
Simon Beyaert, Aléna Borys, Pamela Baldin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2025
Tumor-informed ctDNA assay to predict outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with PD-1 inhibitor
Natasha Honoré, George Laliotis, Vasily N Aushev, et al.
Cancer Research
|
February 19, 2021
Dynamic Regulation of Expression of KRAS and Its Effectors Determines the Ability to Initiate Tumorigenesis in Pancreatic Acinar Cells
Mohamad Assi, Younes Achouri, Axelle Loriot, et al.
Access Microbiology
|
July 23, 2025
Primary iliac bone tuberculosis: a case report
Hajar Dahou, Fataou Saley Younoussa, Imane Aragon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2023
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor
Natasha Honoré, Athenaïs van der Elst, Anna Dietz, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 25, 2026
Reciprocal signaling-metabolic crosstalk between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers
Engy Vigneron, Julie Vignau, Olivier Lowyck, et al.
Nature Communications
|
January 31, 2025
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma
Valentin Van den Bossche, Julie Vignau, Engy Vigneron, et al.
Page
of 1